Volpara Health Technologies (ASX: VHT) Webcast Replay
13th October, 2021
Volpara Health Technologies (ASX: VHT) is a fast-growing cancer diagnostics provider with a global presence and leading AI-powered tech.
As a part of our ‘The Insiders: Meet the CEOs’ series, Founder & CEO Ralph Highnam, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 13th October 2021 at 12pm (AEDT).
Join the next The Insider: Meet the CEOs webcast
FEATURED SPEAKER
Ralph Highnam
Founder & CEO - Volpara Health Technologies (ASX: VHT)
Volpara is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Through recent acquisitions, the company has grown its US market share from 5% to 34% in the past five years. Further growth is predicted, with the US expected to mandate the early screening for breast cancer – a significant tailwind for Volpara’s prospects. Volpara’s tech and services are currently used in 35 countries and the company has expanded its footprint in the US$2.8 billion lung screen market.
